Answers are grounded in this paper and cite their sources.
Peripheral neuropathies arise from diverse etiologies and show varied clinical manifestations, underscoring the importance of studies using human dorsal root ganglia (DRG). This study aimed to explore alterations in human DRG by assessing markers across complementary functional domains. Human DRG from 3 controls and 8 patients with varicella zoster virus (VZV), Guillain-Barré syndrome, diabetes mellitus (DM), and familial amyloid polyneuropathy (FAP) were analyzed using immunohistochemistry. We examined glial activation (glial fibrillary acidic protein [GFAP]), intercellular communication (connexin 43 [Cx43]), cell adhesion (neural cell adhesion molecule [NCAM]), and interferon-related responses (myxovirus resistance protein A [MxA]). Overall, heterogeneous marker expression patterns were observed. Glial fibrillary acidic protein expression in satellite glial cells (SGCs) varied across disease entities; in FAP, interstitial GFAP indicated nonmyelinating Schwann cell involvement. Cx43 was increased in chronic diseases within hypertrophic, multilayered SGCs. NCAM revealed diverse localization and clustering patterns, suggesting altered cell adhesion and plasticity. MxA exhibited distinct disease-specific features, including neuronal submembrane condensates in FAP and VZV, cytoplasmic expression in SGCs in VZV, and neuronal cytoplasmic condensates in DM. Importantly, morphologically similar Nageotte nodules displayed distinct molecular profiles. These observations illustrate heterogeneous molecular and cellular features and provide a descriptive framework for future investigations of peripheral neuropathies.
No takes yet. Share an insight, caveat, or question.
Inoue et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: